Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1998 Mar;77(5):683–693. doi: 10.1038/bjc.1998.114

Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target.

A P Zbar 1, N R Lemoine 1, M Wadhwa 1, H Thomas 1, D Snary 1, W A Kmiot 1
PMCID: PMC2149974  PMID: 9514045

Full text

PDF
683

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams D. O., Hall T., Steplewski Z., Koprowski H. Tumors undergoing rejection induced by monoclonal antibodies of the IgG2a isotype contain increased numbers of macrophages activated for a distinctive form of antibody-dependent cytolysis. Proc Natl Acad Sci U S A. 1984 Jun;81(11):3506–3510. doi: 10.1073/pnas.81.11.3506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anichini A., Maccalli C., Mortarini R., Salvi S., Mazzocchi A., Squarcina P., Herlyn M., Parmiani G. Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients. J Exp Med. 1993 Apr 1;177(4):989–998. doi: 10.1084/jem.177.4.989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ansardi D. C., Moldoveanu Z., Porter D. C., Walker D. E., Conry R. M., LoBuglio A. F., McPherson S., Morrow C. D. Characterization of poliovirus replicons encoding carcinoembryonic antigen. Cancer Res. 1994 Dec 15;54(24):6359–6364. [PubMed] [Google Scholar]
  4. Arakawa F., Kuroki M., Misumi Y., Oikawa S., Nakazato H., Matsuoka Y. Characterization of a cDNA clone encoding a new species of the nonspecific cross-reacting antigen (NCA), a member of the CEA gene family. Biochem Biophys Res Commun. 1990 Feb 14;166(3):1063–1071. doi: 10.1016/0006-291x(90)90975-s. [DOI] [PubMed] [Google Scholar]
  5. August D. A., Ottow R. T., Sugarbaker P. H. Clinical perspective of human colorectal cancer metastasis. Cancer Metastasis Rev. 1984;3(4):303–324. doi: 10.1007/BF00051457. [DOI] [PubMed] [Google Scholar]
  6. Austin E. B., Robins R. A., Baldwin R. W., Durrant L. G. Induction of delayed hypersensitivity to human tumor cells with a human monoclonal anti-idiotypic antibody. J Natl Cancer Inst. 1991 Sep 4;83(17):1245–1248. doi: 10.1093/jnci/83.17.1245. [DOI] [PubMed] [Google Scholar]
  7. Baillie C. T., Winslet M. C., Bradley N. J. Tumour vasculature--a potential therapeutic target. Br J Cancer. 1995 Aug;72(2):257–267. doi: 10.1038/bjc.1995.323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bates P. A., Luo J., Sternberg M. J. A predicted three-dimensional structure for the carcinoembryonic antigen (CEA). FEBS Lett. 1992 Apr 20;301(2):207–214. doi: 10.1016/0014-5793(92)81249-l. [DOI] [PubMed] [Google Scholar]
  9. Bennink J. R., Yewdell J. W., Smith G. L., Moller C., Moss B. Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells. Nature. 1984 Oct 11;311(5986):578–579. doi: 10.1038/311578a0. [DOI] [PubMed] [Google Scholar]
  10. Berling B., Kolbinger F., Grunert F., Thompson J. A., Brombacher F., Buchegger F., von Kleist S., Zimmermann W. Cloning of a carcinoembryonic antigen gene family member expressed in leukocytes of chronic myeloid leukemia patients and bone marrow. Cancer Res. 1990 Oct 15;50(20):6534–6539. [PubMed] [Google Scholar]
  11. Bernards R., Destree A., McKenzie S., Gordon E., Weinberg R. A., Panicali D. Effective tumor immunotherapy directed against an oncogene-encoded product using a vaccinia virus vector. Proc Natl Acad Sci U S A. 1987 Oct;84(19):6854–6858. doi: 10.1073/pnas.84.19.6854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Bhattacharya-Chatterjee M., Mukerjee S., Biddle W., Foon K. A., Köhler H. Murine monoclonal anti-idiotype antibody as a potential network antigen for human carcinoembryonic antigen. J Immunol. 1990 Oct 15;145(8):2758–2765. [PubMed] [Google Scholar]
  13. Bird R. E., Hardman K. D., Jacobson J. W., Johnson S., Kaufman B. M., Lee S. M., Lee T., Pope S. H., Riordan G. S., Whitlow M. Single-chain antigen-binding proteins. Science. 1988 Oct 21;242(4877):423–426. doi: 10.1126/science.3140379. [DOI] [PubMed] [Google Scholar]
  14. Blottiere H. M., Douillard J. Y., Koprowski H., Steplewski Z. Humoral and cellular responses of colorectal cancer patients treated with monoclonal antibodies and interferon gamma. Cancer Immunol Immunother. 1990;32(1):29–37. doi: 10.1007/BF01741721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Boehm M. K., Mayans M. O., Thornton J. D., Begent R. H., Keep P. A., Perkins S. J. Extended glycoprotein structure of the seven domains in human carcinoembryonic antigen by X-ray and neutron solution scattering and an automated curve fitting procedure: implications for cellular adhesion. J Mol Biol. 1996 Jun 21;259(4):718–736. doi: 10.1006/jmbi.1996.0353. [DOI] [PubMed] [Google Scholar]
  16. Bona C. A. Idiotype network theory and its implications in anti-tumor immunity. Prog Clin Biol Res. 1989;288:215–221. [PubMed] [Google Scholar]
  17. Bretscher P., Cohn M. A theory of self-nonself discrimination. Science. 1970 Sep 11;169(3950):1042–1049. doi: 10.1126/science.169.3950.1042. [DOI] [PubMed] [Google Scholar]
  18. Brüggemann M., Winter G., Waldmann H., Neuberger M. S. The immunogenicity of chimeric antibodies. J Exp Med. 1989 Dec 1;170(6):2153–2157. doi: 10.1084/jem.170.6.2153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Capecchi M. R. Altering the genome by homologous recombination. Science. 1989 Jun 16;244(4910):1288–1292. doi: 10.1126/science.2660260. [DOI] [PubMed] [Google Scholar]
  20. Chakraborty M., Foon K. A., Kohler H., Bhattacharya-Chatterjee M. Preclinical evaluation in nonhuman primates of an anti-idiotypic antibody that mimicks the carcinoembryonic antigen. J Immunother Emphasis Tumor Immunol. 1995 Aug;18(2):95–103. doi: 10.1097/00002371-199508000-00003. [DOI] [PubMed] [Google Scholar]
  21. Chattopadhyay P., Starkey J., Morrow W. J., Raychaudhuri S. Murine monoclonal anti-idiotope antibody breaks unresponsiveness and induces a specific antibody response to human melanoma-associated proteoglycan antigen in cynomolgus monkeys. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2684–2688. doi: 10.1073/pnas.89.7.2684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Chelyapov N. V., Antonova T. P., Yanova N. N., Chernos V. I. Antigenic properties of vaccinia virus and of the virus recombinant strains expressing heterologous genes. Acta Virol. 1988 Sep;32(5):409–416. [PubMed] [Google Scholar]
  23. Chen L., Linsley P. S., Hellström K. E. Costimulation of T cells for tumor immunity. Immunol Today. 1993 Oct;14(10):483–486. doi: 10.1016/0167-5699(93)90262-J. [DOI] [PubMed] [Google Scholar]
  24. Collatz E., Von Kleist S., Burtin P. Further investigations of circulating antibodies in colon cancer patients: on the autoantigenicity of the carcinoembryonic antigen. Int J Cancer. 1971 Sep 15;8(2):298–303. doi: 10.1002/ijc.2910080215. [DOI] [PubMed] [Google Scholar]
  25. Conry R. M., LoBuglio A. F., Curiel D. T. Polynucleotide-mediated immunization therapy of cancer. Semin Oncol. 1996 Feb;23(1):135–147. [PubMed] [Google Scholar]
  26. Conry R. M., LoBuglio A. F., Kantor J., Schlom J., Loechel F., Moore S. E., Sumerel L. A., Barlow D. L., Abrams S., Curiel D. T. Immune response to a carcinoembryonic antigen polynucleotide vaccine. Cancer Res. 1994 Mar 1;54(5):1164–1168. [PubMed] [Google Scholar]
  27. Conry R. M., LoBuglio A. F., Loechel F., Moore S. E., Sumerel L. A., Barlow D. L., Pike J., Curiel D. T. A carcinoembryonic antigen polynucleotide vaccine for human clinical use. Cancer Gene Ther. 1995 Mar;2(1):33–38. [PubMed] [Google Scholar]
  28. Conry R. M., LoBuglio A. F., Wright M., Sumerel L., Pike M. J., Johanning F., Benjamin R., Lu D., Curiel D. T. Characterization of a messenger RNA polynucleotide vaccine vector. Cancer Res. 1995 Apr 1;55(7):1397–1400. [PubMed] [Google Scholar]
  29. Conry R. M., Widera G., LoBuglio A. F., Fuller J. T., Moore S. E., Barlow D. L., Turner J., Yang N. S., Curiel D. T. Selected strategies to augment polynucleotide immunization. Gene Ther. 1996 Jan;3(1):67–74. [PubMed] [Google Scholar]
  30. Coupar B. E., Andrew M. E., Boyle D. B. A general method for the construction of recombinant vaccinia viruses expressing multiple foreign genes. Gene. 1988 Aug 15;68(1):1–10. doi: 10.1016/0378-1119(88)90593-8. [DOI] [PubMed] [Google Scholar]
  31. Durbin H., Young S., Stewart L. M., Wrba F., Rowan A. J., Snary D., Bodmer W. F. An epitope on carcinoembryonic antigen defined by the clinically relevant antibody PR1A3. Proc Natl Acad Sci U S A. 1994 May 10;91(10):4313–4317. doi: 10.1073/pnas.91.10.4313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Durrant L. G., Buckley T. J., Denton G. W., Hardcastle J. D., Sewell H. F., Robins R. A. Enhanced cell-mediated tumor killing in patients immunized with human monoclonal antiidiotypic antibody 105AD7. Cancer Res. 1994 Sep 15;54(18):4837–4840. [PubMed] [Google Scholar]
  33. Eades-Perner A. M., Zimmermann W. Carcinoembryonic antigen-transgenic mice: a model for tumor immunotherapy. Tumour Biol. 1995;16(1):56–61. doi: 10.1159/000217929. [DOI] [PubMed] [Google Scholar]
  34. Edwards R. H., Rutter W. J. Use of vaccinia virus vectors to study protein processing in human disease. Normal nerve growth factor processing and secretion in cultured fibroblasts from patients with familial dysautonomia. J Clin Invest. 1988 Jul;82(1):44–47. doi: 10.1172/JCI113599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Eichmann K., Rajewsky K. Induction of T and B cell immunity by anti-idiotypic antibody. Eur J Immunol. 1975 Oct;5(10):661–666. doi: 10.1002/eji.1830051002. [DOI] [PubMed] [Google Scholar]
  36. Eisenbraun M. D., Fuller D. H., Haynes J. R. Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunization. DNA Cell Biol. 1993 Nov;12(9):791–797. doi: 10.1089/dna.1993.12.791. [DOI] [PubMed] [Google Scholar]
  37. Estin C. D., Stevenson U. S., Plowman G. D., Hu S. L., Sridhar P., Hellström I., Brown J. P., Hellström K. E. Recombinant vaccinia virus vaccine against the human melanoma antigen p97 for use in immunotherapy. Proc Natl Acad Sci U S A. 1988 Feb;85(4):1052–1056. doi: 10.1073/pnas.85.4.1052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Fearon E. R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990 Jun 1;61(5):759–767. doi: 10.1016/0092-8674(90)90186-i. [DOI] [PubMed] [Google Scholar]
  39. Fell H. P., Gayle M. A., Grosmaire L., Ledbetter J. A. Genetic construction and characterization of a fusion protein consisting of a chimeric F(ab') with specificity for carcinomas and human IL-2. J Immunol. 1991 Apr 1;146(7):2446–2452. [PubMed] [Google Scholar]
  40. Ferguson M. A. Colworth Medal Lecture. Glycosyl-phosphatidylinositol membrane anchors: the tale of a tail. Biochem Soc Trans. 1992 May;20(2):243–256. doi: 10.1042/bst0200243. [DOI] [PubMed] [Google Scholar]
  41. Finke J. H., Rayman P., Edinger M., Tubbs R. R., Stanley J., Klein E., Bukowski R. Characterization of a human renal cell carcinoma specific cytotoxic CD8+ T cell line. J Immunother (1991) 1992 Jan;11(1):1–11. doi: 10.1097/00002371-199201000-00001. [DOI] [PubMed] [Google Scholar]
  42. Goebels N., Michaelis D., Wekerle H., Hohlfeld R. Human myoblasts as antigen-presenting cells. J Immunol. 1992 Jul 15;149(2):661–667. [PubMed] [Google Scholar]
  43. Gold J. M., Freedman S. O., Gold P. Human anti-CEA antibodies detected by radioimmunoelectrophoresis. Nat New Biol. 1972 Sep 13;239(89):60–62. doi: 10.1038/newbio239060a0. [DOI] [PubMed] [Google Scholar]
  44. Goodnow C. C., Brink R., Adams E. Breakdown of self-tolerance in anergic B lymphocytes. Nature. 1991 Aug 8;352(6335):532–536. doi: 10.1038/352532a0. [DOI] [PubMed] [Google Scholar]
  45. Granowska M., Britton K. E., Mather S. J., Morris G., Ellison D., Soobramoney S., Talbot I. C., Northover J. M. Radioimmunoscintigraphy with technetium-99m labelled monoclonal antibody, 1A3, in colorectal cancer. Eur J Nucl Med. 1993 Aug;20(8):690–698. doi: 10.1007/BF00181760. [DOI] [PubMed] [Google Scholar]
  46. Granowska M., Jass J. R., Britton K. E., Northover J. M. A prospective study of the use of 111In-labelled monoclonal antibody against carcino-embryonic antigen in colorectal cancer and of some biological factors affecting its uptake. Int J Colorectal Dis. 1989;4(2):97–108. doi: 10.1007/BF01646868. [DOI] [PubMed] [Google Scholar]
  47. Hamming J. F., Schelfhout L. J., Cornelisse C. J., van de Velde C. J., Goslings B. M., Hermans J., Fleuren G. J. Prognostic value of nuclear DNA content in papillary and follicular thyroid cancer. World J Surg. 1988 Aug;12(4):503–508. doi: 10.1007/BF01655433. [DOI] [PubMed] [Google Scholar]
  48. Hardingham J. E., Kotasek D., Farmer B., Butler R. N., Mi J. X., Sage R. E., Dobrovic A. Immunobead-PCR: a technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction. Cancer Res. 1993 Aug 1;53(15):3455–3458. [PubMed] [Google Scholar]
  49. Harlan D. M., Abe R., Lee K. P., June C. H. Potential roles of the B7 and CD28 receptor families in autoimmunity and immune evasion. Clin Immunol Immunopathol. 1995 May;75(2):99–111. doi: 10.1006/clin.1995.1058. [DOI] [PubMed] [Google Scholar]
  50. Hedley D. W., Clark G. M., Cornelisse C. J., Killander D., Kute T., Merkel D. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Report of the DNA Cytometry Consensus Conference. Cytometry. 1993;14(5):482–485. doi: 10.1002/cyto.990140505. [DOI] [PubMed] [Google Scholar]
  51. Hefta L. J., Schrewe H., Thompson J. A., Oikawa S., Nakazato H., Shively J. E. Expression of complementary DNA and genomic clones for carcinoembryonic antigen and nonspecific cross-reacting antigen in Chinese hamster ovary and mouse fibroblast cells and characterization of the membrane-expressed products. Cancer Res. 1990 Apr 15;50(8):2397–2403. [PubMed] [Google Scholar]
  52. Hefta S. A., Hefta L. J., Lee T. D., Paxton R. J., Shively J. E. Carcinoembryonic antigen is anchored to membranes by covalent attachment to a glycosylphosphatidylinositol moiety: identification of the ethanolamine linkage site. Proc Natl Acad Sci U S A. 1988 Jul;85(13):4648–4652. doi: 10.1073/pnas.85.13.4648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Herlyn D. M., Koprowski H. Monoclonal anticolon carcinoma antibodies in complement-dependent cytotoxicity. Int J Cancer. 1981 Jun 15;27(6):769–774. doi: 10.1002/ijc.2910270607. [DOI] [PubMed] [Google Scholar]
  54. Hodge J. W., McLaughlin J. P., Kantor J. A., Schlom J. Diversified prime and boost protocols using recombinant vaccinia virus and recombinant non-replicating avian pox virus to enhance T-cell immunity and antitumor responses. Vaccine. 1997 Apr-May;15(6-7):759–768. doi: 10.1016/s0264-410x(96)00238-1. [DOI] [PubMed] [Google Scholar]
  55. Hohlfeld R., Engel A. G. The immunobiology of muscle. Immunol Today. 1994 Jun;15(6):269–274. doi: 10.1016/0167-5699(94)90006-X. [DOI] [PubMed] [Google Scholar]
  56. Hollinshead A. C., McWright C. G., Alford TC GLEW D. H., Gold P., Herbeman R. B. Separation of skin reactive intestinal cancer antigen from the carcinoembryonic antigen of Gold. Science. 1972 Sep 8;177(4052):887–889. doi: 10.1126/science.177.4052.887. [DOI] [PubMed] [Google Scholar]
  57. Hu S. L., Plowman G. D., Sridhar P., Stevenson U. S., Brown J. P., Estin C. D. Characterization of a recombinant vaccinia virus expressing human melanoma-associated antigen p97. J Virol. 1988 Jan;62(1):176–180. doi: 10.1128/jvi.62.1.176-180.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Ioannides C. G., Freedman R. S., Platsoucas C. D., Rashed S., Kim Y. P. Cytotoxic T cell clones isolated from ovarian tumor-infiltrating lymphocytes recognize multiple antigenic epitopes on autologous tumor cells. J Immunol. 1991 Mar 1;146(5):1700–1707. [PubMed] [Google Scholar]
  59. Jain R. K. Determinants of tumor blood flow: a review. Cancer Res. 1988 May 15;48(10):2641–2658. [PubMed] [Google Scholar]
  60. Jain R. K. Transport of molecules in the tumor interstitium: a review. Cancer Res. 1987 Jun 15;47(12):3039–3051. [PubMed] [Google Scholar]
  61. Jerne N. K. Towards a network theory of the immune system. Ann Immunol (Paris) 1974 Jan;125C(1-2):373–389. [PubMed] [Google Scholar]
  62. Jiao S., Williams P., Berg R. K., Hodgeman B. A., Liu L., Repetto G., Wolff J. A. Direct gene transfer into nonhuman primate myofibers in vivo. Hum Gene Ther. 1992 Feb;3(1):21–33. doi: 10.1089/hum.1992.3.1-21. [DOI] [PubMed] [Google Scholar]
  63. Johnson P. W., Burchill S. A., Selby P. J. The molecular detection of circulating tumour cells. Br J Cancer. 1995 Aug;72(2):268–276. doi: 10.1038/bjc.1995.324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Kantor J., Abrams S., Irvine K., Snoy P., Kaufman H., Schlom J. Specific immunotherapy using a recombinant vaccinia virus expressing human carcinoembryonic antigen. Ann N Y Acad Sci. 1993 Aug 12;690:370–373. doi: 10.1111/j.1749-6632.1993.tb44034.x. [DOI] [PubMed] [Google Scholar]
  65. Kantor J., Irvine K., Abrams S., Kaufman H., DiPietro J., Schlom J. Antitumor activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine. J Natl Cancer Inst. 1992 Jul 15;84(14):1084–1091. doi: 10.1093/jnci/84.14.1084. [DOI] [PubMed] [Google Scholar]
  66. Kantor J., Irvine K., Abrams S., Snoy P., Olsen R., Greiner J., Kaufman H., Eggensperger D., Schlom J. Immunogenicity and safety of a recombinant vaccinia virus vaccine expressing the carcinoembryonic antigen gene in a nonhuman primate. Cancer Res. 1992 Dec 15;52(24):6917–6925. [PubMed] [Google Scholar]
  67. Kantor J., Tran R., Greiner J., Pestka S., Fisher P. B., Shively J. E., Schlom J. Modulation of carcinoembryonic antigen messenger RNA levels in human colon carcinoma cells by recombinant human gamma-interferon. Cancer Res. 1989 May 15;49(10):2651–2655. [PubMed] [Google Scholar]
  68. Kapsopoulou-Dominos K., Anderer F. A. An approach to the routine estimation of circulating carcinoembryonic antigen immune complexes in patients with carcinomata of the gastrointestinal tract. Clin Exp Immunol. 1979 Jul;37(1):25–32. [PMC free article] [PubMed] [Google Scholar]
  69. Kaufman H., Schlom J., Kantor J. A recombinant vaccinia virus expressing human carcinoembryonic antigen (CEA). Int J Cancer. 1991 Jul 30;48(6):900–907. doi: 10.1002/ijc.2910480618. [DOI] [PubMed] [Google Scholar]
  70. Konstadoulakis M. M., Syrigos K. N., Albanopoulos C., Mayers G., Golematis B. The presence of anti-carcinoembryonic antigen (CEA) antibodies in the sera of patients with gastrointestinal malignancies. J Clin Immunol. 1994 Sep;14(5):310–313. doi: 10.1007/BF01540984. [DOI] [PubMed] [Google Scholar]
  71. Kradin R. L., Kurnick J. T., Lazarus D. S., Preffer F. I., Dubinett S. M., Pinto C. E., Gifford J., Davidson E., Grove B., Callahan R. J. Tumour-infiltrating lymphocytes and interleukin-2 in treatment of advanced cancer. Lancet. 1989 Mar 18;1(8638):577–580. doi: 10.1016/s0140-6736(89)91609-7. [DOI] [PubMed] [Google Scholar]
  72. Lejtenyi M. C., Freedman S. O., Gold P. Response of lymphocytes from patients with gastrointestinal cancer to the carcinoembryonic antigen of the human digestive system. Cancer. 1971 Jul;28(1):115–120. doi: 10.1002/1097-0142(197107)28:1<115::aid-cncr2820280121>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  73. Leusch H. G., Hefta S. A., Drzeniek Z., Hummel K., Markos-Pusztai Z., Wagener C. Escherichia coli of human origin binds to carcinoembryonic antigen (CEA) and non-specific crossreacting antigen (NCA). FEBS Lett. 1990 Feb 26;261(2):405–409. doi: 10.1016/0014-5793(90)80603-g. [DOI] [PubMed] [Google Scholar]
  74. Lindemann F., Schlimok G., Dirschedl P., Witte J., Riethmüller G. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet. 1992 Sep 19;340(8821):685–689. doi: 10.1016/0140-6736(92)92230-d. [DOI] [PubMed] [Google Scholar]
  75. Lo Gerfo P., Herter F. P., Bennett S. J. Absence of circulating antibodies to carcinoembryonic antigen in patients with gastrointestinal malignancies. Int J Cancer. 1972 Mar 15;9(2):344–348. doi: 10.1002/ijc.2910090212. [DOI] [PubMed] [Google Scholar]
  76. MacSween J. M. The antigenicity of carcinoembryonic antigen in man. Int J Cancer. 1975 Feb 15;15(2):246–252. doi: 10.1002/ijc.2910150210. [DOI] [PubMed] [Google Scholar]
  77. Mavligit G. M., Ambus U., Gutterman J. U., Hersh E. M., McBride C. M. Antigen solubilized from human solid tumours: lymphocyte stimulation and cutaneous delayed hypersensitivity. Nat New Biol. 1973 Jun 6;243(127):188–190. doi: 10.1038/newbio243188a0. [DOI] [PubMed] [Google Scholar]
  78. Mavligit G. M., Gutterman J. U., McBride C. M., Hersh E. M. Cell-mediated immunity to human solid tumors: in vitro detection by lymphocyte blastogenic responses to cell-associated and solubilized tumor antigens. Natl Cancer Inst Monogr. 1973 Jun;37:167–176. [PubMed] [Google Scholar]
  79. Mavligit G. M., Stuckey S. Colorectal carcinoma. Evidence for circulating CEA-anti-CEA complexes. Cancer. 1983 Jul 1;52(1):146–149. doi: 10.1002/1097-0142(19830701)52:1<146::aid-cncr2820520126>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  80. Mayforth R. D., Quintáns J. Designer and catalytic antibodies. N Engl J Med. 1990 Jul 19;323(3):173–178. doi: 10.1056/NEJM199007193230306. [DOI] [PubMed] [Google Scholar]
  81. Miller J. F., Morahan G. Peripheral T cell tolerance. Annu Rev Immunol. 1992;10:51–69. doi: 10.1146/annurev.iy.10.040192.000411. [DOI] [PubMed] [Google Scholar]
  82. Mittelman A., Chen Z. J., Yang H., Wong G. Y., Ferrone S. Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma. Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):466–470. doi: 10.1073/pnas.89.2.466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Miyatake S., Handa H., Yamashita J., Yamasaki T., Ueda M., Namba Y., Hanaoka M. Induction of human glioma-specific cytotoxic T-lymphocyte lines by autologous tumor stimulation and interleukin 2. J Neurooncol. 1986;4(1):55–64. doi: 10.1007/BF02158003. [DOI] [PubMed] [Google Scholar]
  84. Monson J. R., Ramsden C., Guillou P. J. Decreased interleukin-2 production in patients with gastrointestinal cancer. Br J Surg. 1986 Jun;73(6):483–486. doi: 10.1002/bjs.1800730620. [DOI] [PubMed] [Google Scholar]
  85. Morrissey P. J., Bressler L., Park L. S., Alpert A., Gillis S. Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells. J Immunol. 1987 Aug 15;139(4):1113–1119. [PubMed] [Google Scholar]
  86. Morton B. A., O'Connor-Tressel M., Beatty B. G., Shively J. E., Beatty J. D. Artifactual CEA elevation due to human anti-mouse antibodies. Arch Surg. 1988 Oct;123(10):1242–1246. doi: 10.1001/archsurg.1988.01400340068012. [DOI] [PubMed] [Google Scholar]
  87. Moss B., Flexner C. Vaccinia virus expression vectors. Annu Rev Immunol. 1987;5:305–324. doi: 10.1146/annurev.iy.05.040187.001513. [DOI] [PubMed] [Google Scholar]
  88. Moss B., Smith G. L., Gerin J. L., Purcell R. H. Live recombinant vaccinia virus protects chimpanzees against hepatitis B. Nature. 1984 Sep 6;311(5981):67–69. doi: 10.1038/311067a0. [DOI] [PubMed] [Google Scholar]
  89. Muraro R., Wunderlich D., Thor A., Lundy J., Noguchi P., Cunningham R., Schlom J. Definition by monoclonal antibodies of a repertoire of epitopes on carcinoembryonic antigen differentially expressed in human colon carcinomas versus normal adult tissues. Cancer Res. 1985 Nov;45(11 Pt 2):5769–5780. [PubMed] [Google Scholar]
  90. Nap M., Mollgard K., Burtin P., Fleuren G. J. Immunohistochemistry of carcino-embryonic antigen in the embryo, fetus and adult. Tumour Biol. 1988;9(2-3):145–153. doi: 10.1159/000217555. [DOI] [PubMed] [Google Scholar]
  91. Nieroda C. A., Milenic D. E., Carrasquillo J. A., Scholm J., Greiner J. W. Improved tumor radioimmunodetection using a single-chain Fv and gamma-interferon: potential clinical applications for radioimmunoguided surgery and gamma scanning. Cancer Res. 1995 Jul 1;55(13):2858–2865. [PubMed] [Google Scholar]
  92. Nijman H. W., Houbiers J. G., Vierboom M. P., van der Burg S. H., Drijfhout J. W., D'Amaro J., Kenemans P., Melief C. J., Kast W. M. Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes. Eur J Immunol. 1993 Jun;23(6):1215–1219. doi: 10.1002/eji.1830230603. [DOI] [PubMed] [Google Scholar]
  93. Nossal G. J. Cellular mechanisms of immunologic tolerance. Annu Rev Immunol. 1983;1:33–62. doi: 10.1146/annurev.iy.01.040183.000341. [DOI] [PubMed] [Google Scholar]
  94. Nossal G. J., Pike B. L. Clonal anergy: persistence in tolerant mice of antigen-binding B lymphocytes incapable of responding to antigen or mitogen. Proc Natl Acad Sci U S A. 1980 Mar;77(3):1602–1606. doi: 10.1073/pnas.77.3.1602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Oosterwijk E., Warnaar S. O., Zwartendijk J., van der Velde E. A., Fleuren G. J., Cornelisse C. J. Relationship between DNA ploidy, antigen expression and survival in renal cell carcinoma. Int J Cancer. 1988 Nov 15;42(5):703–708. doi: 10.1002/ijc.2910420512. [DOI] [PubMed] [Google Scholar]
  96. Osborne M. P., Wong G. Y., Asina S., Old L. J., Cote R. J., Rosen P. P. Sensitivity of immunocytochemical detection of breast cancer cells in human bone marrow. Cancer Res. 1991 May 15;51(10):2706–2709. [PubMed] [Google Scholar]
  97. Peoples G. E., Goedegebuure P. S., Andrews J. V., Schoof D. D., Eberlein T. J. HLA-A2 presents shared tumor-associated antigens derived from endogenous proteins in ovarian cancer. J Immunol. 1993 Nov 15;151(10):5481–5491. [PubMed] [Google Scholar]
  98. Pertmer T. M., Eisenbraun M. D., McCabe D., Prayaga S. K., Fuller D. H., Haynes J. R. Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine. 1995;13(15):1427–1430. doi: 10.1016/0264-410x(95)00069-d. [DOI] [PubMed] [Google Scholar]
  99. Pressman D., Chu T. M., Grossberg A. L. Carcinoembryonic antigen-binding immunoglobulin isolated from normal human serum by affinity chromatography. Transplant Proc. 1980 Mar;12(1):195–197. [PubMed] [Google Scholar]
  100. Ragnhammar P., Fagerberg J., Frödin J. E., Hjelm A. L., Lindemalm C., Magnusson I., Masucci G., Mellstedt H. Effect of monoclonal antibody 17-1A and GM-CSF in patients with advanced colorectal carcinoma--long-lasting, complete remissions can be induced. Int J Cancer. 1993 Mar 12;53(5):751–758. doi: 10.1002/ijc.2910530508. [DOI] [PubMed] [Google Scholar]
  101. Ragnhammar P., Fagerberg J., Frödin J. E., Wersäll P., Hansson L. O., Mellstedt H. Granulocyte/macrophage-colony-stimulating factor augments the induction of antibodies, especially anti-idiotypic antibodies, to therapeutic monoclonal antibodies. Cancer Immunol Immunother. 1995 Jun;40(6):367–375. doi: 10.1007/BF01525387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Raychaudhuri S., Kang C. Y., Kaveri S. V., Kieber-Emmons T., Köhler H. Tumor idiotype vaccines. VII. Analysis and correlation of structural, idiotypic, and biologic properties of protective and nonprotective Ab2. J Immunol. 1990 Jul 15;145(2):760–767. [PubMed] [Google Scholar]
  103. Richman P. I., Bodmer W. F. Monoclonal antibodies to human colorectal epithelium: markers for differentiation and tumour characterization. Int J Cancer. 1987 Mar 15;39(3):317–328. doi: 10.1002/ijc.2910390309. [DOI] [PubMed] [Google Scholar]
  104. Riethmüller G., Johnson J. P. Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancers. Curr Opin Immunol. 1992 Oct;4(5):647–655. doi: 10.1016/0952-7915(92)90041-c. [DOI] [PubMed] [Google Scholar]
  105. Riethmüller G., Schneider-Gädicke E., Schlimok G., Schmiegel W., Raab R., Höffken K., Gruber R., Pichlmaier H., Hirche H., Pichlmayr R. Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group. Lancet. 1994 May 14;343(8907):1177–1183. doi: 10.1016/s0140-6736(94)92398-1. [DOI] [PubMed] [Google Scholar]
  106. Robins R. A., Denton G. W., Hardcastle J. D., Austin E. B., Baldwin R. W., Durrant L. G. Antitumor immune response and interleukin 2 production induced in colorectal cancer patients by immunization with human monoclonal anti-idiotypic antibody. Cancer Res. 1991 Oct 1;51(19):5425–5429. [PubMed] [Google Scholar]
  107. Rodenburg C. J., Cornelisse C. J., Heintz P. A., Hermans J., Fleuren G. J. Tumor ploidy as a major prognostic factor in advanced ovarian cancer. Cancer. 1987 Jan 15;59(2):317–323. doi: 10.1002/1097-0142(19870115)59:2<317::aid-cncr2820590225>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  108. Rosa F. M., Fellous M. Regulation of HLA-DR gene by IFN-gamma. Transcriptional and post-transcriptional control. J Immunol. 1988 Mar 1;140(5):1660–1664. [PubMed] [Google Scholar]
  109. Rosenberg S. A., Lotze M. T., Yang J. C., Aebersold P. M., Linehan W. M., Seipp C. A., White D. E. Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients. Ann Surg. 1989 Oct;210(4):474–485. doi: 10.1097/00000658-198910000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Schlimok G., Funke I., Bock B., Schweiberer B., Witte J., Riethmüller G. Epithelial tumor cells in bone marrow of patients with colorectal cancer: immunocytochemical detection, phenotypic characterization, and prognostic significance. J Clin Oncol. 1990 May;8(5):831–837. doi: 10.1200/JCO.1990.8.5.831. [DOI] [PubMed] [Google Scholar]
  111. Shortman K. Cellular aspects of early T-cell development. Curr Opin Immunol. 1992 Apr;4(2):140–146. doi: 10.1016/0952-7915(92)90003-w. [DOI] [PubMed] [Google Scholar]
  112. Sidransky D., Tokino T., Hamilton S. R., Kinzler K. W., Levin B., Frost P., Vogelstein B. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science. 1992 Apr 3;256(5053):102–105. doi: 10.1126/science.1566048. [DOI] [PubMed] [Google Scholar]
  113. Sieff C. A., Emerson S. G., Donahue R. E., Nathan D. G., Wang E. A., Wong G. G., Clark S. C. Human recombinant granulocyte-macrophage colony-stimulating factor: a multilineage hematopoietin. Science. 1985 Dec 6;230(4730):1171–1173. doi: 10.1126/science.3877981. [DOI] [PubMed] [Google Scholar]
  114. Slingluff C. L., Jr, Cox A. L., Henderson R. A., Hunt D. F., Engelhard V. H. Recognition of human melanoma cells by HLA-A2.1-restricted cytotoxic T lymphocytes is mediated by at least six shared peptide epitopes. J Immunol. 1993 Apr 1;150(7):2955–2963. [PubMed] [Google Scholar]
  115. Slovin S. F., Lackman R. D., Ferrone S., Kiely P. E., Mastrangelo M. J. Cellular immune response to human sarcomas: cytotoxic T cell clones reactive with autologous sarcomas. I. Development, phenotype, and specificity. J Immunol. 1986 Nov 1;137(9):3042–3048. [PubMed] [Google Scholar]
  116. Sorokin J. J., Kupchik H. Z., Zamcheck N. Brief communication: carcinoembryonic antigen in colon cancer: absence in perchloric acid precipitates of plasma. J Natl Cancer Inst. 1973 Sep;51(3):1081–1083. doi: 10.1093/jnci/51.3.1081. [DOI] [PubMed] [Google Scholar]
  117. Staab H. J., Anderer F. A., Stumpf E., Fischer R. Are circulating CEA immune complexes a prognostic marker in patients with carcinoma of the gastrointestinal tract? Br J Cancer. 1980 Jul;42(1):26–33. doi: 10.1038/bjc.1980.199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Steplewski Z., Herlyn D., Lubeck M., Kimoto Y., Herlyn M., Koprowski H. Mechanisms of tumor growth inhibition. Hybridoma. 1986 Jul;5 (Suppl 1):S59–S64. [PubMed] [Google Scholar]
  119. Steplewski Z., Lubeck M. D., Koprowski H. Human macrophages armed with murine immunoglobulin G2a antibodies to tumors destroy human cancer cells. Science. 1983 Aug 26;221(4613):865–867. doi: 10.1126/science.6879183. [DOI] [PubMed] [Google Scholar]
  120. Thompson J. A., Grunert F., Zimmermann W. Carcinoembryonic antigen gene family: molecular biology and clinical perspectives. J Clin Lab Anal. 1991;5(5):344–366. doi: 10.1002/jcla.1860050510. [DOI] [PubMed] [Google Scholar]
  121. Thompson J., Zimmermann W. The carcinoembryonic antigen gene family: structure, expression and evolution. Tumour Biol. 1988;9(2-3):63–83. doi: 10.1159/000217547. [DOI] [PubMed] [Google Scholar]
  122. Trauth B. C., Klas C., Peters A. M., Matzku S., Möller P., Falk W., Debatin K. M., Krammer P. H. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science. 1989 Jul 21;245(4915):301–305. doi: 10.1126/science.2787530. [DOI] [PubMed] [Google Scholar]
  123. Tsang K. Y., Zaremba S., Nieroda C. A., Zhu M. Z., Hamilton J. M., Schlom J. Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine. J Natl Cancer Inst. 1995 Jul 5;87(13):982–990. doi: 10.1093/jnci/87.13.982. [DOI] [PubMed] [Google Scholar]
  124. Tynan K., Olsen A., Trask B., de Jong P., Thompson J., Zimmermann W., Carrano A., Mohrenweiser H. Assembly and analysis of cosmid contigs in the CEA-gene family region of human chromosome 19. Nucleic Acids Res. 1992 Apr 11;20(7):1629–1636. doi: 10.1093/nar/20.7.1629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Ura Y., Ochi Y., Hamazu M., Ishida M., Nakajima K., Watanabe T. Studies on circulating antibody against carcinoembryonic antigen (CEA) and CEA-like antigen in cancer patients. Cancer Lett. 1985 Jan;25(3):283–295. doi: 10.1016/s0304-3835(15)30008-2. [DOI] [PubMed] [Google Scholar]
  126. Wadhwa M., Bird C., Fagerberg J., Gaines-Das R., Ragnhammar P., Mellstedt H., Thorpe R. Production of neutralizing granulocyte-macrophage colony-stimulating factor (GM-CSF) antibodies in carcinoma patients following GM-CSF combination therapy. Clin Exp Immunol. 1996 May;104(2):351–358. doi: 10.1046/j.1365-2249.1996.11704.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Wang B., Boyer J., Srikantan V., Coney L., Carrano R., Phan C., Merva M., Dang K., Agadjanan M., Gilbert L. DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and nonhuman primates. DNA Cell Biol. 1993 Nov;12(9):799–805. doi: 10.1089/dna.1993.12.799. [DOI] [PubMed] [Google Scholar]
  128. Williams A. F., Barclay A. N. The immunoglobulin superfamily--domains for cell surface recognition. Annu Rev Immunol. 1988;6:381–405. doi: 10.1146/annurev.iy.06.040188.002121. [DOI] [PubMed] [Google Scholar]
  129. Winter G., Milstein C. Man-made antibodies. Nature. 1991 Jan 24;349(6307):293–299. doi: 10.1038/349293a0. [DOI] [PubMed] [Google Scholar]
  130. Wolff J. A., Ludtke J. J., Acsadi G., Williams P., Jani A. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum Mol Genet. 1992 Sep;1(6):363–369. doi: 10.1093/hmg/1.6.363. [DOI] [PubMed] [Google Scholar]
  131. Wolff J. A., Malone R. W., Williams P., Chong W., Acsadi G., Jani A., Felgner P. L. Direct gene transfer into mouse muscle in vivo. Science. 1990 Mar 23;247(4949 Pt 1):1465–1468. doi: 10.1126/science.1690918. [DOI] [PubMed] [Google Scholar]
  132. Wyllie A. H., Kerr J. F., Currie A. R. Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68:251–306. doi: 10.1016/s0074-7696(08)62312-8. [DOI] [PubMed] [Google Scholar]
  133. Wölfel T., Schneider J., Meyer Zum Büschenfelde K. H., Rammensee H. G., Rötzschke O., Falk K. Isolation of naturally processed peptides recognized by cytolytic T lymphocytes (CTL) on human melanoma cells in association with HLA-A2.1. Int J Cancer. 1994 May 1;57(3):413–418. doi: 10.1002/ijc.2910570320. [DOI] [PubMed] [Google Scholar]
  134. Yang N. S., Burkholder J., Roberts B., Martinell B., McCabe D. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc Natl Acad Sci U S A. 1990 Dec;87(24):9568–9572. doi: 10.1073/pnas.87.24.9568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Zhou X., Berglund P., Zhao H., Liljeström P., Jondal M. Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus. Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):3009–3013. doi: 10.1073/pnas.92.7.3009. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES